oAlert.pl

Recalled Medicines & supplements – Current GIS Alerts 2026

Found 698 recalled products in the Medicines & supplements category. Check batch numbers, shops, and hazard information.

Common hazards in this category

All recalled products

Elocom – recalled product

Elocom

HIGH 29.03.2023

A risk was identified that Elocom cream 1mg/g was marketed in outer cartons intended for the ointment, resulting in an incorrect description of the dosage form and uncertainty for patients. Potential effects: misuse of the medicine, lack of efficacy or increased adverse reactions.

Elocom – recalled product

Elocom

HIGH 29.03.2023

A risk was identified of placing on the market Elocom 1 mg/g cream packed in outer cartons for the “ointment” dosage form, causing labeling inconsistent with the contents and potentially misleading patients. Potential effects: improper use of the medicine, lack of expected efficacy, skin complications.

Melisa Fix – recalled product

Melisa Fix

MEDIUM 24.03.2023

The Chief Pharmaceutical Inspector states that the quality defect does not allow exclusion of the possibility of exceeding the acceptable daily intake limit of Stevia rebaudiana. Potential effects: adverse effects related to excessive intake, metabolic disturbances, lack of safe use.

MORFİN HİDROKLORÜR Osel 0.01 g/1 ml – recalled product

MORFİN HİDROKLORÜR Osel 0.01 g/1 ml

CRITICAL 08.03.2023

Lack of efficient and safe opening of ampoules, irregular breaking, injuries to staff and glass crumbling that may enter the ampoule interior and pose a risk to patients. Potential effects: cuts, contamination of the solution with glass, complications after intravenous administration.

Tirosint Sol – recalled product

Tirosint Sol

CRITICAL 08.03.2023

Due to the reduced active substance content found in the above-mentioned batches, the risk to patient health resulting from decreased drug efficacy cannot be excluded. Potential effects: reduced effectiveness of hypothyroidism treatment, worsening of disease symptoms.

Tirosint Sol – recalled product

Tirosint Sol

HIGH 08.03.2023

Due to the reduced content of the active substance in the specified batches, the risk to patient health from decreased medicinal efficacy cannot be excluded. Potential effects: ineffective treatment of thyroid disorders, worsening of hypothyroidism symptoms, cardiovascular complications in susceptible patients.

Tirosint Sol – recalled product

Tirosint Sol

MEDIUM 08.03.2023

Due to the reduced content of the active substance in these batches, the risk to patient health resulting from decreased effectiveness of the medicine cannot be excluded. Potential effects: reduced effectiveness of thyroid hormone therapy, possible worsening of hypothyroidism symptoms.

Tirosint Sol – recalled product

Tirosint Sol

MEDIUM 08.03.2023

Due to the reduced content of the active substance found in these batches, the risk to patient health resulting from decreased effectiveness of the medicine cannot be ruled out. Potential effects: ineffective treatment of hypothyroidism, worsening of disease symptoms, health complications.

Tirosint Sol – recalled product

Tirosint Sol

MEDIUM 08.03.2023

Reduced content of the active substance – levothyroxine sodium – was found in the listed batches, which may lead to decreased effectiveness of the medicine and a health risk for the patient. Potential effects: reduced efficacy of hypothyroidism treatment, deterioration of health, recurrence of disease symptoms.

Tirosint Sol – recalled product

Tirosint Sol

MEDIUM 08.03.2023

Due to the reduced content of the active substance found in these batches, a risk to patient health arising from decreased drug effectiveness cannot be excluded. Potential effects: reduced treatment efficacy, possible worsening of thyroid disease symptoms.

Tirosint Sol – recalled product

Tirosint Sol

MEDIUM 08.03.2023

Due to the reduced content of the active substance in the listed batches, the risk to patient health resulting from decreased effectiveness of the medicine cannot be excluded. Potential effects: ineffective treatment, exacerbation of thyroid disease, hormonal complications.

Tirosint Sol – recalled product

Tirosint Sol

MEDIUM 08.03.2023

Due to the reduced content of the active substance found in these batches, a health risk for the patient resulting from decreased efficacy of the medicine cannot be excluded. Potential effects: reduced effectiveness of hypothyroidism treatment, worsening of health status, possible complications.

Tirosint Sol – recalled product

Tirosint Sol

MEDIUM 08.03.2023

Due to the reduced content of the active substance in these batches, a risk to patient health from decreased therapeutic efficacy cannot be excluded. Potential effects: lack of treatment efficacy, worsening of health condition.

ADRENALIN OSEL (Adrenaline), 1 mg/1 mL IM/IV/SC Solution for Injection, Ampułka a 1 mg/ml, – recalled product

ADRENALIN OSEL (Adrenaline), 1 mg/1 mL IM/IV/SC Solution for Injection, Ampułka a 1 mg/ml,

CRITICAL 03.03.2023

Based on the collected data there is a risk to patients’ health and life due to the inability to use this life‑saving medicine and the possibility of administering a solution contaminated with glass. Potential effects: life‑threatening complications, tissue damage, acute systemic reactions.

ADRENALIN OSEL 1 mg/1 mL IM/IV/SC Solution for Injection – recalled product

ADRENALIN OSEL 1 mg/1 mL IM/IV/SC Solution for Injection

CRITICAL 23.02.2023

Breaking of the ampoule and inability to open the medicine normally, creating uncertainty whether glass fragments entered the interior and contaminated the solution, posing a threat to the patient’s health and life. Potential effects: life‑threatening complications after injection, tissue damage, lack of effective treatment.

Tirosint Sol – recalled product

Tirosint Sol

MEDIUM 21.02.2023

Due to the reduced active substance content found in these batches, a risk to patient health from decreased medicinal efficacy cannot be excluded. Potential effects: reduced treatment efficacy, disease worsening, complications related to insufficient therapy.

Tirosint Sol – recalled product

Tirosint Sol

MEDIUM 21.02.2023

Due to the reduced content of the active substance found in the above-mentioned batches, a risk to patient health arising from decreased effectiveness of the medicine cannot be ruled out. Potential effects: lack of treatment efficacy, worsening of disease symptoms.

Tirosint Sol – recalled product

Tirosint Sol

MEDIUM 21.02.2023

A reduced content of the active substance (levothyroxine) was found in five batches, with out-of-specification results and levels below the established limit, which may lead to decreased drug effectiveness and health risk for patients. Potential effects: reduced efficacy of hypothyroidism treatment, possible worsening of disease symptoms.

Tirosint Sol – recalled product

Tirosint Sol

MEDIUM 21.02.2023

Due to the reduced active substance content found in the above-mentioned batches, a risk to patient health from decreased efficacy of the medicine cannot be excluded. Potential effects: lack of treatment effectiveness, worsening disease control, possible complications of thyroid disorders.

Tirosint Sol – recalled product

Tirosint Sol

MEDIUM 21.02.2023

A decrease in active substance content below the limit and out-of-specification results for levothyroxine content were found, which may lead to reduced effectiveness of the medicine, and a risk to patient health cannot be excluded. Potential effects: reduced treatment effectiveness, worsening of disease symptoms, possible complications resulting from hypothyroidism.

What to do if you bought a recalled product?

If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.